CRISPR Will Likely Not Solve Bird Flu
By Carol Cardona and Michelle Kromm,
Scientific American
| 03. 11. 2024
Recently, a group of scientists announced a breakthrough approach to combat Highly Pathogenic Avian Influenza (bird flu or avian flu), a severe illness of birds that has killed millions of chickens worldwide since it emerged in 1996 and continues to devastate bird populations. This disease has quickly become a potential threat to human health and has affected both food prices and availability.
Their approach uses a gene-editing technique called CRISPR/Cas9. In general, this method changes defined segments of an animal’s genetic code to functionally alter what that code does. In this case, CRISPR was used to alter chickens’ genetic code to make chickens more resistant to avian flu. While this was a fascinating use of the technology, any time scientific innovation affects the food we eat, it becomes a sensitive issue. On top of philosophical concerns regarding the use of CRISPR within our food supply, we think there are too many unpredictable outcomes related to combating avian influenza with CRISPR-modified chickens to expect this technology will be a solution to this destructive disease.
While CRISPR has created almost infinite opportunities...
Related Articles
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...